Safety and Efficacy Dose of Artesunate Used in Combination With LAPDAP Treatment of Uncomplicated Falciparum Malaria

NCT00519467 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

120

Enrollment

INDUSTRY

Sponsor class

Conditions

Malaria

Interventions

DRUG: Chlorproguanil-dapsone-artesunate (CDA)

Sponsor

GlaxoSmithKline